1. Home
  2. ENTX vs FKWL Comparison

ENTX vs FKWL Comparison

Compare ENTX & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • FKWL
  • Stock Information
  • Founded
  • ENTX 2010
  • FKWL 1981
  • Country
  • ENTX Israel
  • FKWL United States
  • Employees
  • ENTX N/A
  • FKWL N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FKWL Telecommunications Equipment
  • Sector
  • ENTX Health Care
  • FKWL Utilities
  • Exchange
  • ENTX Nasdaq
  • FKWL Nasdaq
  • Market Cap
  • ENTX 69.6M
  • FKWL 67.3M
  • IPO Year
  • ENTX 2018
  • FKWL 1996
  • Fundamental
  • Price
  • ENTX $1.79
  • FKWL $4.87
  • Analyst Decision
  • ENTX Strong Buy
  • FKWL
  • Analyst Count
  • ENTX 1
  • FKWL 0
  • Target Price
  • ENTX $10.00
  • FKWL N/A
  • AVG Volume (30 Days)
  • ENTX 30.9K
  • FKWL 37.1K
  • Earning Date
  • ENTX 05-09-2025
  • FKWL 05-14-2025
  • Dividend Yield
  • ENTX N/A
  • FKWL N/A
  • EPS Growth
  • ENTX N/A
  • FKWL N/A
  • EPS
  • ENTX N/A
  • FKWL N/A
  • Revenue
  • ENTX $181,000.00
  • FKWL $43,443,375.00
  • Revenue This Year
  • ENTX N/A
  • FKWL N/A
  • Revenue Next Year
  • ENTX N/A
  • FKWL N/A
  • P/E Ratio
  • ENTX N/A
  • FKWL N/A
  • Revenue Growth
  • ENTX N/A
  • FKWL N/A
  • 52 Week Low
  • ENTX $1.41
  • FKWL $2.90
  • 52 Week High
  • ENTX $2.79
  • FKWL $7.45
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 49.59
  • FKWL 35.37
  • Support Level
  • ENTX $1.50
  • FKWL $4.77
  • Resistance Level
  • ENTX $1.84
  • FKWL $5.08
  • Average True Range (ATR)
  • ENTX 0.11
  • FKWL 0.39
  • MACD
  • ENTX 0.03
  • FKWL -0.05
  • Stochastic Oscillator
  • ENTX 85.50
  • FKWL 17.42

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

Share on Social Networks: